Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244749 · ClinicalTrials.gov registry record
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 26
- Enrollment target
NCT02244749: Completed study, sponsored by University of California, Irvine.
NCT02244749 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02244749 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precancerous or cancerous lesions, and can compare the concentrations of these compounds to determine the difference between the two areas. The result can lead to further understanding of skin cancers and pre-cancers. Because skin cancers and pre-cancers are so common, any knowledge would be very useful for many people in the future and may be used for development of future treatments or prevention strategies.
Primary Outcome
Overall, compare normal skin versus precancerous lesions or skin cancer from the same individual. Paired tests of samples are selected from the same subjects. * 10 actinic keratosis samples, * 10 basal cell carcinoma samples * 20 squamous cell carcinoma samples * Normal skin control biopsy from the same subject will be collected.
Interventions
- OTHER skin specimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-08 |
What the finished NCT02244749 record still lists
NCT02244749 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which skin specimen is the first listed.
NCT02244749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02244749 about?
NCT02244749 is a clinical study titled "Role of Metabolic Enzymes in Non-Melanoma Skin Cancer". The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precan...
What is the current status of trial NCT02244749?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02244749?
The interventions under investigation include: skin specimen (OTHER).
Who is sponsoring clinical trial NCT02244749?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia